Chemed Co. (NYSE:CHE) Shares Purchased by Thrivent Financial for Lutherans

Thrivent Financial for Lutherans raised its position in Chemed Co. (NYSE:CHE) by 25.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 146,017 shares of the company’s stock after acquiring an additional 29,445 shares during the quarter. Thrivent Financial for Lutherans owned 0.97% of Chemed worth $87,752,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. GAMMA Investing LLC boosted its position in Chemed by 34.4% in the 2nd quarter. GAMMA Investing LLC now owns 86 shares of the company’s stock valued at $47,000 after buying an additional 22 shares during the last quarter. American National Bank & Trust acquired a new stake in Chemed during the 3rd quarter valued at approximately $61,000. EntryPoint Capital LLC increased its holdings in Chemed by 14.0% during the 1st quarter. EntryPoint Capital LLC now owns 147 shares of the company’s stock worth $94,000 after purchasing an additional 18 shares during the last quarter. Mather Group LLC. raised its position in shares of Chemed by 60.5% in the 2nd quarter. Mather Group LLC. now owns 183 shares of the company’s stock valued at $99,000 after purchasing an additional 69 shares in the last quarter. Finally, Quarry LP boosted its stake in shares of Chemed by 721.7% during the 2nd quarter. Quarry LP now owns 189 shares of the company’s stock valued at $103,000 after buying an additional 166 shares during the last quarter. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Insiders Place Their Bets

In related news, EVP Nicholas Michael Westfall sold 1,713 shares of Chemed stock in a transaction on Monday, September 9th. The stock was sold at an average price of $569.35, for a total value of $975,296.55. Following the transaction, the executive vice president now directly owns 6,109 shares in the company, valued at $3,478,159.15. The trade was a 21.90 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction dated Thursday, September 26th. The stock was sold at an average price of $598.81, for a total value of $1,197,620.00. Following the sale, the chief executive officer now owns 103,735 shares in the company, valued at approximately $62,117,555.35. The trade was a 1.89 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 4,313 shares of company stock worth $2,527,495. Insiders own 3.32% of the company’s stock.

Analysts Set New Price Targets

Separately, Royal Bank of Canada reduced their price objective on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating on the stock in a research note on Tuesday, November 5th.

Chemed Trading Down 0.8 %

Shares of NYSE CHE opened at $557.95 on Monday. The company has a market capitalization of $8.40 billion, a price-to-earnings ratio of 28.19, a price-to-earnings-growth ratio of 2.37 and a beta of 0.46. Chemed Co. has a twelve month low of $523.33 and a twelve month high of $654.62. The business has a 50 day simple moving average of $580.37 and a 200-day simple moving average of $565.38.

Chemed (NYSE:CHE) last announced its quarterly earnings results on Tuesday, October 29th. The company reported $5.64 earnings per share for the quarter, missing analysts’ consensus estimates of $5.76 by ($0.12). The company had revenue of $606.18 million for the quarter, compared to analyst estimates of $612.22 million. Chemed had a return on equity of 27.86% and a net margin of 12.69%. The firm’s revenue for the quarter was up 7.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $5.32 earnings per share. As a group, equities analysts predict that Chemed Co. will post 21.43 earnings per share for the current year.

Chemed Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, December 6th. Shareholders of record on Monday, November 18th will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 0.36%. The ex-dividend date is Monday, November 18th. Chemed’s payout ratio is 10.11%.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.